Allergan plc (AGN.N)
BRIEF-Allergan Receives FDA Clearance For The CoolSculpting Treatment To Improve Appearance Of Lax Tissue In The Double Chin
* ALLERGAN RECEIVES FDA CLEARANCE FOR THE COOLSCULPTING TREATMENT TO IMPROVE APPEARANCE OF LAX TISSUE IN THE DOUBLE CHIN Source text for Eikon: Further company coverage:
* REPROS THERAPEUTICS INC.® ANNOUNCES ACQUISITION BY ALLERGAN PLC
Dec 8 Teva Pharmaceutical Industries Ltd is considering cutting up to 10,000 jobs as CEO Kare Schultz seeks to reduce $1.5 billion to $2 billion in costs over the next two years, Bloomberg reported, citing people familiar with the matter.
(The following statement was released by the rating agency) CHICAGO, December 07 (Fitch) Fitch Ratings has affirmed the ratings of Allergan plc (Allergan; NYSE: AGN) and subsidiaries at 'BBB-'. The Rating Outlook is Stable. Fitch has also affirmed and withdrawn the 'BBB-' IDRs of Allergan's subsidiaries, Warner Chilcott Limited and Allergan Finance LLC. These IDRs are no longer considered by Fitch to be relevant to the agency's coverage. A full list of rating actions, which apply to approximatel
Over 30 technology companies including Alphabet Inc , Amazon.com Inc and Facebook Inc. on Friday urged a U.S. patent court to disregard drugmaker Allergan Plc's contention that its transfer of some of its patents to a Native American tribe shields them from the court's review.
Dec 1 Over 30 technology companies including Alphabet Inc, Amazon.com Inc and Facebook Inc. on Friday urged a U.S. patent court to disregard drugmaker Allergan Plc's contention that its transfer of some of its patents to a Native American tribe shields them from the court's review.
JERUSALEM, Nov 27 Teva Pharmaceutical Industries needs to take "deep, meaningful steps around the world" to secure its future, it said in a letter to the Israeli parliament on Monday, after media reports the company is set to cut thousands of jobs.
TEL AVIV, Nov 23 Teva Pharmaceutical is expected to cut up to a quarter of its 6,860-strong workforce in Israel, and a few thousand more staff in the United States, media reported Thursday, though a minister said the figures may not be accurate.
TEL AVIV Teva Pharmaceutical Industries is expected to cut 20-25 percent of its workforce in Israel, where it employs 6,860 people, and a few thousand more jobs are to go in the United States, financial news website Calcalist said on Thursday.
TEL AVIV, Nov 23 Teva Pharmaceutical Industries is expected to cut 20-25 percent of its 6,860 workers in Israel and a few thousand more in the United States, financial news website Calcalist reported on Thursday.